This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/14/2022
The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1. The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1.
Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference call to discuss the company's third quarter 2022 financial results and business update. My name is Michelle and I will be your operator for today's call. At this time, all participants are in a listen-only mode. There will be a question and answer session to follow. Please be advised this call is being recorded at Infinity's request. Now I would like to introduce your host for today's call, Jane Kaufman. Please go ahead.
Thank you, Michelle, and good morning, everyone. Welcome to today's call to discuss our third quarter 2022 financial results and the Mario 3 data update that we announced in a separate press release earlier this morning. Both press releases are available on our website at infi.com. On the call with me today are Adeline Perkins, Chief Executive Officer and Chair, Larry Block, President, and Robert Elaria, Jr., Chief Medical Officer. We will open up the call for Q&A following our remarks. Please note that during this call, we may make forward-looking statements about our future expectations and plans, including clinical development objectives, the therapeutic potential of our product candidates, our strategic plans, and financial projections. Our actual results may differ materially from what we project today due to a number of important factors, including the consideration considerations described in the risk factors section of our annual report on Form 10-K for 2021 and in other filings we make with the SEC. These forward-looking statements represent our views only as of today, and we caution you that we may not update them in the future, whether as a result of new information, future events, or otherwise. Now, I'd like to turn the call over to Adeline.
You're reading a preview of the INFI Q3 2022 earnings call.
Free account.
